Bulletin
Investor Alert

Market Pulse Archives

Aug. 19, 2022, 8:43 a.m. EDT

23andMe stock falls after company says CFO to depart

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    23andMe Holding Co. (ME)

or Cancel Already have a watchlist? Log In

By Emily Bary

ME

Shares of 23andMe Holding Co. /zigman2/quotes/222659849/composite ME -4.35% were falling more than 7% in premarket trading Friday after the DNA-testing company disclosed that Chief Financial Officer Stevem Schoch was resigning from the company. He will stop being 23andMe's "principal financial officer and principal accounting officer" as of Sept. 1, though he intends to stay with the company through Sept. 30 to help with the transition. The resignation "is not the result of any dispute or disagreement with the Company, including any matters relating to the Company's accounting practices or financial reporting," 23andMe said in a filing with the Securities and Exchange Commission. Joseph Selsavage will serve as 23andMe's interim chief financial and accounting officer. He is currently the chief financial officer of Lemonaid Health, which 23andMe acquired in November.

/zigman2/quotes/222659849/composite
US : U.S.: Nasdaq
$ 2.86
-0.13 -4.35%
Volume: 2.73M
Sept. 30, 2022 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$1.35 billion
Rev. per Employee
$360,895
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.